206 related articles for article (PubMed ID: 23490027)
1. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life.
Pedersen SS; Chaitsing R; Szili-Torok T; Jordaens L; Theuns DA
Am J Cardiol; 2013 May; 111(10):1443-7. PubMed ID: 23490027
[TBL] [Abstract][Full Text] [Related]
2. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
[TBL] [Abstract][Full Text] [Related]
3. Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues.
Fluur C; Bolse K; Strömberg A; Thylén I
Heart Lung; 2013; 42(3):202-7. PubMed ID: 23273655
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations.
Hill L; McIlfatrick S; Taylor BJ; Dixon L; Cole BR; Moser DK; Fitzsimons D
Eur J Cardiovasc Nurs; 2016 Feb; 15(1):20-9. PubMed ID: 25903823
[TBL] [Abstract][Full Text] [Related]
5. Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study.
Thylén I; Moser DK; Strömberg A
BMC Geriatr; 2018 Oct; 18(1):250. PubMed ID: 30342484
[TBL] [Abstract][Full Text] [Related]
6. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
Waterhouse E; Ahmad F
Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091
[TBL] [Abstract][Full Text] [Related]
7. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.
Pedersen SS; van Domburg RT; Theuns DA; Jordaens L; Erdman RA
Am Heart J; 2005 Apr; 149(4):664-9. PubMed ID: 15990750
[TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
[TBL] [Abstract][Full Text] [Related]
9. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators.
Wójcicka M; Lewandowski M; Smolis-Bak E; Szwed H
Kardiol Pol; 2008 Oct; 66(10):1050-8; discussion 1059-60. PubMed ID: 19006026
[TBL] [Abstract][Full Text] [Related]
10. Quality of life and end-of-life issues for older patients with implanted cardiac rhythm devices.
Lampert R
Clin Geriatr Med; 2012 Nov; 28(4):693-702. PubMed ID: 23101578
[TBL] [Abstract][Full Text] [Related]
11. Deactivation of implantable cardioverter-defibrillators at end of life.
Pettit SJ; Jackson CE; Gardner RS
Future Cardiol; 2013 Nov; 9(6):885-96. PubMed ID: 24180544
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.
Kelley AS; Reid MC; Miller DH; Fins JJ; Lachs MS
Am Heart J; 2009 Apr; 157(4):702-8.e1. PubMed ID: 19332199
[TBL] [Abstract][Full Text] [Related]
13. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy.
Sherazi S; McNitt S; Aktas MK; Polonsky B; Shah AH; Moss AJ; Daubert JP; Zareba W
Pacing Clin Electrophysiol; 2013 Oct; 36(10):1273-9. PubMed ID: 23731284
[TBL] [Abstract][Full Text] [Related]
14. "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators.
Goldstein NE; Mehta D; Siddiqui S; Teitelbaum E; Zeidman J; Singson M; Pe E; Bradley EH; Morrison RS
J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):7-12. PubMed ID: 18095037
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of the EOL-ICDQ as a measure of experiences, attitudes and knowledge in end-of-life in patients living with an implantable cardioverter defibrillator.
Thylén I; Wenemark M; Fluur C; Strömberg A; Bolse K; Årestedt K
Eur J Cardiovasc Nurs; 2014 Apr; 13(2):142-51. PubMed ID: 24298191
[TBL] [Abstract][Full Text] [Related]
16. Documented consent process for implantable cardioverter-defibrillators and implications for end-of-life care in older adults.
Niewald A; Broxterman J; Rosell T; Rigler S
J Med Ethics; 2013 Feb; 39(2):94-7. PubMed ID: 23139392
[TBL] [Abstract][Full Text] [Related]
17. Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation.
Pedersen SS; Theuns DA; Jordaens L; Kupper N
Europace; 2010 Aug; 12(8):1119-26. PubMed ID: 20507853
[TBL] [Abstract][Full Text] [Related]
18. Determinants and trajectory of phobic anxiety in patients living with an implantable cardioverter defibrillator.
Cho EN; von Känel R; Marten-Mittag B; Ronel J; Kolb C; Baumert J; Ladwig KH
Heart; 2012 May; 98(10):806-12. PubMed ID: 22543838
[TBL] [Abstract][Full Text] [Related]
19. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator.
Sherazi S; Daubert JP; Block RC; Jeevanantham V; Abdel-Gadir K; DiSalle MR; Haley JM; Shah AH
Mayo Clin Proc; 2008 Oct; 83(10):1139-41. PubMed ID: 18828973
[TBL] [Abstract][Full Text] [Related]
20. ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life.
Strömberg A; Fluur C; Miller J; Chung ML; Moser DK; Thylén I
Pacing Clin Electrophysiol; 2014 Jul; 37(7):834-42. PubMed ID: 24483943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]